Matthew Helmut Kulke, MD
Chief, Hematology/Oncology, Co-Director, Cancer Center
Existing Patients
Make an appointment by phone
617.638.6428
Make an appointment with MyChart
Book with MyChart
New Patients
If you are a new patient and need an appointment, please contact us at the phone number below.
Learn more about coming to BMC. 617.638.6428Refer a Patient
Refer a patient
Call for assistance with the referral process
617.638.6428
-
Specialties
Neuroendocrine tumors, gastrointestinal cancer, carcinoid tumors
-
Departments
My Contact Information
- 617.638.6428
-
Primary Location
830 Harrison Avenue
3rd Floor
Boston, MA 02118
More About Me
-
Administrative Title
Zoltan Kohn Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine. Member, Evans Center for Interdisciplinary Biomedical Research, Boston University. Member, Shipley Prostate Cancer Research Center at Boston University Chobanian & Avedisian School of Medicine. -
Education
University of California San Francisco School of Medicine, 1992 -
Residency
Internal Medicine, Brigham and Women’s Hospital -
Fellowship
Medical Oncology, Dana-Farber Cancer Institute -
Board Certifications
Medical Oncology, American Board of Internal Medicine -
Special Interests
Neuroendocrine tumors, gastrointestinal cancer, carcinoid tumors
Affiliations
Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.
My Videos
Latest from HealthCity
BMC Aims to Offer Costly, One-Time Cancer Therapy To All
CAR T, a personalized cell therapy, has been a game-changer for certain blood cancers, but its high cost has been a huge barrier to equitable access.

Partnership Targets Better Diversity in Cancer Clinical Trials
A new collaboration among Boston cancer centers aims to increase minority populations’ access to the latest treatments for more equitable outcomes.

Etoposide and Other Clinical Trials for COVID-19 Inflammation
At Boston Medical Center, experts from the Cancer Center are exploring how new and existing therapies could fight the COVID infection.
